Abstract
Background
The aim of this study was to assess the clinicopathologic characteristics of patients with Paget’s disease of the vulva who were treated by our gynecologic oncology service between 1985 and 2010.
Methods
Vulvar Paget’s disease patient demographics, pathologic diagnosis, treatment and follow-up data were reviewed over a 25-year period.
Results
The vulvar Paget’s disease patients were primarily (62.5%) treated with a partial simple vulvectomy. Three patients had a history of malignancy, although none of them was intercurrent. Eleven patients had microscopically positive margins, 5 of whom developed progressive disease. Conversely, 5 patients had negative margins, of whom 4 had recurrent disease. There was a significant relationship between the presence of invasive disease and patient progression-free interval (PFI) (p = 0.007), but margin status and lesion size did not correlate with PFI (p > 0.05). Median patient PFI and follow-up was 30 and 53 months, respectively.
Conclusions
We found a significant relationship between the presence of invasive disease and patient PFI in vulvar Paget’s disease although the presence of microscopic positive margins and lesion size were not prognostic indicators. In patients with high risk factors, prolonged surveillance should be considered an essential component of optimal patient management.
Similar content being viewed by others
References
Abell DA (1973) Simple vulvectomy—a 10-year review. Aust N Z J Obstet Gynaecol 13:8–14
Awtrey CS, Marshall DS, Soslow RA et al (2003) Clinically inapparent invasive vulvar carcinoma in an area of persistent Paget’s disease: a case report. Gynecol Oncol 88:440–443
Baehrendtz H, Einhorn N, Pettersson F et al (1994) Paget’s disease of the vulva: the Radiumhemmet series 1975–1990. Int J Gynecol Cancer 4:1–6
Bakalianou K, Salakos N, Iavazzo C et al (2008) Paget’s disease of the vulva. A ten-year experience. Eur J Gynaecol Oncol 29:368–370
Bergen S, DiSaia PJ, Liao SY et al (1989) Conservative management of extramammary Paget’s disease of the vulva. Gynecol Oncol 33:151–156
Black D, Tornos C, Soslow RA et al (2007) The outcomes of patients with positive margins after excision for intraepithelial Paget’s disease of the vulva. Gynecol Oncol 104:547–550
Chanda JJ (1985) Extramammary Paget’s disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol 13:1009–1014
Crawford D, Nimmo M, Clement PB et al (1999) Prognostic factors in Paget’s disease of the vulva: a study of 21 cases. Int J Gynecol Pathol 18:351–359
Curtin JP, Rubin SC, Jones WB et al (1990) Paget’s disease of the vulva. Gynecol Oncol 39:374–377
Niikura H, Yoshida H, Ito K et al (2006) Paget’s disease of the vulva: clinicopathologic study of type 1 cases treated at a single institution. Int J Gynecol Cancer 16:1212–1215
Ewing T, Sawicki J, Ciaravino G et al (2004) Microinvasive Paget’s disease. Gynecol Oncol 95:755–758
Wilkinson EJ, Brown HM (2002) Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol 33:549–554
Parker LP, Parker JR, Bodurka-Bevers D et al (2000) Paget’s disease of the vulva: pathology, pattern of involvement, and prognosis. Gynecol Oncol 77:183–189
Kurman RJ (2002) Blaunnstein’s pathology of the female genital tract, 5th edn. Springer, New York
Ewing TL (1991) Paget’s disease of the vulva treated by combined surgery and laser. Gynecol Oncol 43:137–140
Fanning J, Lambert HC, Hale TM et al (1999) Paget’s disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget’s disease, and recurrence after surgical excision. Am J Obstet Gynecol 180:24–27
Fishman DA, Chambers SK, Schwartz PE et al (1995) Extramammary Paget’s disease of the vulva. Gynecol Oncol 56:266–270
Habif TP (1996) Clinical Dermatology: a color guide to diagnosis and therapy, 3rd edn. Mosby, St. Louis
MacLean AB, Makwana M, Ellis PE et al (2004) The management of Paget’s disease of the vulva. J Obstet Gynaecol 24:124–128
Lee CW, Song MJ, Lee SH et al (2011) Clinicopathologic analysis of extramammary Paget’s disease. Eur J Gynaecol Oncol 32:34–36
Qian Z, Zeitoun NC, Shieh S et al (2003) Successful treatment of extramammary Paget’s disease with imiquimod. J Drugs Dermatol 2:73–76
Kodama S, Kaneko T, Saito M et al (1995) A clinicopathologic study of 30 patients with Paget’s disease of the vulva. Gynecol Oncol 56:63–70
Tanaka Y, Kirihara T, Kitamura H et al (2010) Cytologic detection of recurrence in extramammary Paget’s disease of the vulva: a report of two cases. Acta Cytol 54:1007–1012
Roh HJ, Kim DY, Kim JH et al (2010) Paget’s disease of the vulva: evaluation of recurrence relative to symptom duration, volumetric excision of lesion, and surgical margin status. Acta Obstet Gynecol Scand 89:962–965
Tebes S, Cardosi R, Hoffman M (2002) Paget’s disease of the vulva. Am J Obstet Gynecol 187:281–283
Acknowledgments
This study was supported by a grant from the Women’s Cancer Research Foundation.
Conflict of interest
The authors have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Mendivil, A.A., Abaid, L., Epstein, H.D. et al. Paget’s disease of the vulva: a clinicopathologic institutional review. Int J Clin Oncol 17, 569–574 (2012). https://doi.org/10.1007/s10147-011-0325-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-011-0325-0